Domača stranHPX • FRA
add
Hisamitsu Pharmaceutical Co Inc
Prejšnji trg. dan.
25,60 €
Dnevni razpon
25,80 € - 25,80 €
Letni razpon
21,00 € - 28,80 €
Tržna kapitalizacija
364,25 mrd. JPY
Povprečni obseg
6,00
Razm. P/E
-
Dividendna donosnost
-
Primarna borza
TYO
Borzne novice
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
(JPY) | avg. 2024info | Sprememba L/L |
---|---|---|
Prihodek | 39,65 mrd. | 13,66 % |
Stroški poslovanja | 18,75 mrd. | 17,95 % |
Čisti dohodek | 4,31 mrd. | −1,33 % |
Čista dobičkovnost prihodkov | 10,87 | −13,18 % |
Earnings per share | — | — |
EBITDA | 6,35 mrd. | 20,49 % |
Efektivna davčna stopnja | 28,38 % | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
(JPY) | avg. 2024info | Sprememba L/L |
---|---|---|
Denar. in kratkor. naložbe | 122,74 mrd. | −13,22 % |
Skupna sredstva | 350,48 mrd. | 1,79 % |
Skupne obveznosti | 74,55 mrd. | 7,74 % |
Celoten lastniški kapital | 275,92 mrd. | — |
Shares outstanding | 73,34 mio. | — |
Razmerje P/B | 0,01 | — |
Donosnost sredstev | 3,52 % | — |
Donosnost kapitala | 4,46 % | — |
Denarni tok
Neto sprememba denarnih sredstev
(JPY) | avg. 2024info | Sprememba L/L |
---|---|---|
Čisti dohodek | 4,31 mrd. | −1,33 % |
Denar iz dejavnosti | — | — |
Denar iz naložb | — | — |
Denar iz financiranja | — | — |
Neto sprememba denarnih sredstev | — | — |
Prost denarni tok | — | — |
Vizitka
The Hisamitsu Pharmaceutical Co., Inc., headquartered in Saga and Tokyo, is a Japanese multinational pharmaceutical corporation that develops and markets prescription and over-the-counter drug products, especially external pain relieving products such as the transdermal patch. Hisamitsu has specialised in transdermal drug delivery system technology since the introduction of its original line of patches in 1903.
Hisamitsu's products under the Salonpas and Bye-Bye Fever brands are exported to over fifty countries. Hisamitsu also manufactures the Mohrus and Mohrus-Tape lines of external pain relief prescription products for the Japanese drug market. The company also manufactures internal medicines, eyedrops for general application, and the Lifecella Face Mask, a skincare product. Hisamitsu has developed the only over-the-counter transdermal patches approved by the U.S Food and Drug Administration. Wikipedia
Datum ustanovitve
1847
Sedež organizacije
Spletno mesto
Zaposleni
2.759